Utama › Kanser Prostat › Connecticut › New Haven
Kajian klinikal Kanser Prostat di New Haven, CT
20 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar New Haven (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- Yale Cancer Center, New Haven
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Yale University, New Haven
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Mengambil pesertaFasa 1/2
- GSK Investigational Site, New Haven
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Mengambil pesertaFasa 2
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 mi jauh
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · 3 mi jauh
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Mengambil pesertaFasa 2
- Yale Cancer Center, New Haven
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Mengambil pesertaFasa 1
- Yale Cancer Center, New Haven
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
Mengambil pesertaKajian pemerhatian
- Wren Laboratories, Branford · 6 mi jauh
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Yale New Haven Hospital, New Haven
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Mengambil pesertaFasa 2
- New Haven Hospital - Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Yale University School of Medicine, New Haven
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Mengambil pesertaFasa 1
- Yale New Haven Hospital, New Haven
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi jauh
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Mengambil pesertaFasa 1/2
- Yale University (Data Collection Only), New Haven
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Mengambil pesertaKajian pemerhatian
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Yale University, Yale Cancer Center, New Haven
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Mengambil pesertaFasa 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi jauh
- dan 2 lagi
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi jauh
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi jauh
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di New Haven
- Kanser Paru-paru Bukan Sel Kecil41 kajian
- Kanser Payudara37 kajian
- Kanser (semua jenis)33 kajian
- Kanser Metastatik23 kajian
- Kanser Paru-paru22 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher22 kajian
- Kanser Ovari21 kajian
- Kanser Kolorektal20 kajian
- Dos Berlebihan Opioid18 kajian
- Gangguan Penggunaan Alkohol (AUD)17 kajian
- Leukemia Mieloid Akut17 kajian
- Kanser Pankreas16 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.